Park S - Search Results

1

Impact of the Narcotics Information Management System on Opioid Use Among Outpatients With Musculoskeletal and Connective Tissue Disorders: Quasi-Experimental Study Using Interrupted Time Series.

Lee IH, Kim SY, Park S, Ryu JG, Je NK. Lee IH, et al. Among authors: park s. JMIR Public Health Surveill. 2024 Feb 21;10:e47130. doi: 10.2196/47130. JMIR Public Health Surveill. 2024. PMID: 38381481 Free PMC article.

2

Factors That Affect Time to Switch From Warfarin to a Direct Oral Anticoagulant After Change in the Reimbursement Criteria in Patients With Atrial Fibrillation.

Park S, Je NK. Park S, et al. J Cardiovasc Pharmacol Ther. 2020 Jan;25(1):57-64. doi: 10.1177/1074248419868996. Epub 2019 Aug 12. J Cardiovasc Pharmacol Ther. 2020. PMID: 31405298

3

National trends in metformin-based combination therapy of oral hypoglycaemic agents for type 2 diabetes mellitus.

Kim J, Park S, Kim H, Je NK. Kim J, et al. Among authors: park s. Eur J Clin Pharmacol. 2019 Dec;75(12):1723-1730. doi: 10.1007/s00228-019-02751-9. Epub 2019 Sep 2. Eur J Clin Pharmacol. 2019. PMID: 31475315

4

Zolpidem overutilisation among Korean patients with insomnia.

Kim H, Park S, Kim J, Je NK. Kim H, et al. Among authors: park s. J Sleep Res. 2020 Aug;29(4):e13071. doi: 10.1111/jsr.13071. Epub 2020 May 14. J Sleep Res. 2020. PMID: 32406572

5

Medication utilization among adult patients with attention-deficit/hyperactivity disorder after reimbursement criteria change.

Kim E, Park S, Kim Y, Je NK. Kim E, et al. Among authors: park s. Int Clin Psychopharmacol. 2020 Nov;35(6):329-337. doi: 10.1097/YIC.0000000000000332. Int Clin Psychopharmacol. 2020. PMID: 32897929

6

Factors Influencing the Selection of Non-Vitamin K Antagonist Oral Anticoagulants for Stroke Prevention in Patients With Non-Valvular Atrial Fibrillation.

Park S, Je NK. Park S, et al. J Cardiovasc Pharmacol Ther. 2021 Nov;26(6):656-664. doi: 10.1177/10742484211049919. Epub 2021 Sep 24. J Cardiovasc Pharmacol Ther. 2021. PMID: 34558337

7

Effectiveness and Safety of Regdanvimab in Patients With Mild-To-Moderate COVID-19: A Retrospective Cohort Study.

Park S, Je NK, Kim DW, Park M, Heo J. Park S, et al. Among authors: park m. J Korean Med Sci. 2022 Apr 4;37(13):e102. doi: 10.3346/jkms.2022.37.e102. J Korean Med Sci. 2022. PMID: 35380027 Free PMC article.

8

Utilization of triple antithrombotic therapy in patients with atrial fibrillation undergoing percutaneous coronary intervention.

Choi HJ, Lee Y, Park S, Je NK. Choi HJ, et al. Among authors: park s. Eur J Clin Pharmacol. 2023 Apr;79(4):541-551. doi: 10.1007/s00228-023-03468-6. Epub 2023 Feb 24. Eur J Clin Pharmacol. 2023. PMID: 36823470

9

Temporal trends in use of antisecretory agents among patients administered clopidogrel-based dual antiplatelet therapy after percutaneous coronary intervention.

Lee Y, Choi HJ, Park S, Je NK. Lee Y, et al. Among authors: park s. Pharmacoepidemiol Drug Saf. 2024 Jun;33(6):e5816. doi: 10.1002/pds.5816. Pharmacoepidemiol Drug Saf. 2024. PMID: 38773801

10

Current status and clinical outcomes of pharmacotherapies according to SARS-CoV-2 mutations in patients with mild-to-moderate COVID-19: a retrospective single center study.

Park S, Je NK, Kim DW, Park M, Heo J. Park S, et al. Among authors: park m. BMC Infect Dis. 2024 Sep 3;24(1):871. doi: 10.1186/s12879-024-09765-4. BMC Infect Dis. 2024. PMID: 39223456 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

65,963 results

Search Page

Filters